chr8-85329713-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001128831.4(CA1):āc.645G>Cā(p.Glu215Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000919 in 1,610,948 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001128831.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CA1 | NM_001128831.4 | c.645G>C | p.Glu215Asp | missense_variant | 7/8 | ENST00000523022.6 | NP_001122303.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CA1 | ENST00000523022.6 | c.645G>C | p.Glu215Asp | missense_variant | 7/8 | 1 | NM_001128831.4 | ENSP00000429798 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152130Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000972 AC: 24AN: 246908Hom.: 1 AF XY: 0.0000975 AC XY: 13AN XY: 133318
GnomAD4 exome AF: 0.0000905 AC: 132AN: 1458818Hom.: 1 Cov.: 30 AF XY: 0.0000799 AC XY: 58AN XY: 725472
GnomAD4 genome AF: 0.000105 AC: 16AN: 152130Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74298
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 28, 2023 | The c.645G>C (p.E215D) alteration is located in exon 8 (coding exon 6) of the CA1 gene. This alteration results from a G to C substitution at nucleotide position 645, causing the glutamic acid (E) at amino acid position 215 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at